TherapeuticsMD Inc
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors an… Read more
TherapeuticsMD Inc (TXMD) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.038x
Based on the latest financial reports, TherapeuticsMD Inc (TXMD) has a cash flow conversion efficiency ratio of 0.038x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.05 Million) by net assets ($27.44 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
TherapeuticsMD Inc - Cash Flow Conversion Efficiency Trend (1994–2024)
This chart illustrates how TherapeuticsMD Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
TherapeuticsMD Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of TherapeuticsMD Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
University Bancorp Inc
OTCQB:UNIB
|
0.049x |
|
Three A Resources Bhd
KLSE:0012
|
0.049x |
|
Alony Hetz Properties and Investments Ltd
TA:ALHE
|
0.023x |
|
Sanko Pazarlama Ithalat Ihracat AS
IS:SANKO
|
0.077x |
|
National Plastic Co Ltd Preferred
KO:004255
|
0.027x |
|
Munjal Auto Industries Limited
NSE:MUNJALAU
|
-0.040x |
|
United Recommend International Co Ltd
TWO:5321
|
0.224x |
|
Lycos Energy Inc.
F:G4P0
|
0.075x |
Annual Cash Flow Conversion Efficiency for TherapeuticsMD Inc (1994–2024)
The table below shows the annual cash flow conversion efficiency of TherapeuticsMD Inc from 1994 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $27.37 Million | $732.00K | 0.027x | +101.63% |
| 2023-12-31 | $29.29 Million | $-48.14 Million | -1.644x | -1316.55% |
| 2022-12-31 | $35.14 Million | $-4.08 Million | -0.116x | -107.35% |
| 2021-12-31 | $-93.62 Million | $-147.81 Million | 1.579x | +22.77% |
| 2020-12-31 | $-124.00 Million | $-159.47 Million | 1.286x | +107.14% |
| 2019-12-31 | $9.20 Million | $-165.70 Million | -18.008x | -1544.25% |
| 2018-12-31 | $97.52 Million | $-106.81 Million | -1.095x | -86.83% |
| 2017-12-31 | $129.91 Million | $-76.16 Million | -0.586x | -8.09% |
| 2016-12-31 | $127.49 Million | $-69.14 Million | -0.542x | +56.73% |
| 2015-12-31 | $63.06 Million | $-79.04 Million | -1.253x | -33.24% |
| 2014-12-31 | $48.39 Million | $-45.52 Million | -0.941x | -147.77% |
| 2013-12-31 | $54.70 Million | $-20.77 Million | -0.380x | -104.27% |
| 2012-12-31 | $-1.43 Million | $-12.74 Million | 8.888x | +206.34% |
| 2011-12-31 | $-1.71 Million | $-4.97 Million | 2.901x | +414.65% |
| 2010-12-31 | $-907.55K | $836.83K | -0.922x | -168.72% |
| 2009-12-31 | $-311.05K | $-417.34K | 1.342x | +118.86% |
| 2008-12-31 | $18.70K | $-133.00K | -7.114x | -963.18% |
| 2007-12-31 | $417.54K | $344.10K | 0.824x | +321.58% |
| 2006-12-31 | $1.69 Million | $329.84K | 0.195x | -37.69% |
| 2005-12-31 | $1.31 Million | $412.34K | 0.314x | +58.80% |
| 2004-12-31 | $1.05 Million | $207.73K | 0.198x | +22.22% |
| 2003-12-31 | $866.11K | $140.00K | 0.162x | +18.95% |
| 2002-12-31 | $736.41K | $100.08K | 0.136x | -43.60% |
| 2001-12-31 | $672.09K | $161.95K | 0.241x | +10.07% |
| 2000-12-31 | $611.97K | $133.97K | 0.219x | +116.68% |
| 1999-12-31 | $480.35K | $48.53K | 0.101x | +3.79% |
| 1998-12-31 | $458.12K | $44.60K | 0.097x | -37.48% |
| 1997-12-31 | $497.89K | $77.53K | 0.156x | +35.32% |
| 1996-12-31 | $510.88K | $58.78K | 0.115x | -20.11% |
| 1995-12-31 | $440.53K | $63.45K | 0.144x | -17.20% |
| 1994-12-31 | $418.86K | $72.86K | 0.174x | -- |